세계의 단백질 치료제 시장 : 단백질 기능별, 제품 유형별 예측(2025-2030년)

The Protein Therapeutics Market was valued at USD 78.66 billion in 2023, expected to reach USD 84.80 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 133.98 billion by 2030.

Protein therapeutics encompass a spectrum of treatment modalities derived from engineered proteins, including monoclonal antibodies, insulin, and fusion proteins, primarily targeting a range of diseases such as cancer, hormonal disorders, and autoimmune diseases. These therapies play a crucial role in modern medicine due to their specificity, potency, and reduced side effects compared to traditional treatments. The necessity for protein therapeutics is driven by the increasing prevalence of chronic diseases and the need for personalized medicine, with applications spanning oncology, rare diseases, and metabolic disorders. These therapies are extensively used by pharmaceutical companies, research institutions, and healthcare providers aiming to deliver targeted treatment options. Market growth is propelled by advancements in recombinant DNA technology and an increasing number of FDA approvals for biotherapeutic products. Biopharmaceutical companies are focusing on expanding their clinical pipelines and investing in bioprocessing capabilities to meet the increasing demand. Potential opportunities lie in the expanding biosimilars market and growth in emerging economies where healthcare infrastructure is rapidly developing. However, challenges such as high development costs, stringent regulatory frameworks, and the complexity involved in manufacturing can hinder market growth. Moreover, intellectual property issues and competition from small molecule drugs present additional barriers. Innovations such as AI and machine learning in drug development, novel delivery mechanisms, and the rise of personalized medicine offer significant potential for business growth. Researchers and developers should focus on innovative manufacturing techniques like continuous processing and single-use systems to improve scalability and cost-efficiency. The protein therapeutics market is dynamic, characterized by technological advancements and a strong emphasis on R&D. As companies navigate this landscape, strategic partnerships and collaborations will be essential to leverage expertise and resources effectively, ensuring competitive advantage and sustained market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Therapeutics Market

The Protein Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing healthcare expenditure in the emerging markets
  • Government initiatives to improve the healthcare services
  • Growing geriatric population & rising predominance of chronic diseases
• Market Restraints
  • Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
  • Availability concerns as oral drugs due to denaturation in the gut
• Market Opportunities
  • Potential for bispecific monoclonal antibodies
  • Unmet medical needs in developing countries
• Market Challenges
  • High cost of production and treatment
  • Competition from biosimilars

Porter's Five Forces: A Strategic Tool for Navigating the Protein Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Therapeutics Market

A detailed market share analysis in the Protein Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Therapeutics Market

A strategic analysis of the Protein Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Ambrx, Inc., Amgen,Inc., Aravive, Inc., AstraZeneca Plc, Atomwise Inc., Autolus Therapeutics Plc, Baxter International, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Genentech, Inc., LabGenius Limited, LGC Group, Merck & Co. Inc., Morphic Therapeutic, Inc., Omeros Corporation, Pfizer, Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Protein Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Protein Function, market is studied across Enzymatic & Regulatory, Protein Diagnostics, and Vaccines.
• Based on Product Type, market is studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing healthcare expenditure in the emerging markets
    • 5.1.1.2. Government initiatives to improve the healthcare services
    • 5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
    • 5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential for bispecific monoclonal antibodies
    • 5.1.3.2. Unmet medical needs in developing countries
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of production and treatment
    • 5.1.4.2. Competition from biosimilars
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Therapeutics Market, by Protein Function

• 6.1. Introduction
• 6.2. Enzymatic & Regulatory
• 6.3. Protein Diagnostics
• 6.4. Vaccines

7. Protein Therapeutics Market, by Product Type

• 7.1. Introduction
• 7.2. Blood Clotting Factor
• 7.3. Erythropoietin
• 7.4. Follicle Stimulating Hormone
• 7.5. G-CSF
• 7.6. Insulin
• 7.7. Interferons
• 7.8. Monoclonal Antibodies

8. Americas Protein Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Protein Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Protein Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ambrx, Inc.
• 2. Amgen,Inc.
• 3. Aravive, Inc.
• 4. AstraZeneca Plc
• 5. Atomwise Inc.
• 6. Autolus Therapeutics Plc
• 7. Baxter International, Inc.
• 8. Eli Lilly and Company
• 9. F. Hoffmann-La Roche AG
• 10. Genentech, Inc.
• 11. LabGenius Limited
• 12. LGC Group
• 13. Merck & Co. Inc.
• 14. Morphic Therapeutic, Inc.
• 15. Omeros Corporation
• 16. Pfizer, Inc.
• 17. Sanofi S.A.